ホーム>>Signaling Pathways>> Neuroscience>>L-Isoleucine-13C6

L-Isoleucine-13C6 (Synonyms: L-(+)-Isoleucine-13C6)

カタログ番号GC52323

L-イソロイシンの定量化のための内部標準

Products are for research use only. Not for human use. We do not sell to patients.

L-Isoleucine-13C6 化学構造

Cas No.: 201740-82-1

サイズ 価格 在庫数 個数
5 mg
$106.00
在庫あり
10 mg
$192.00
在庫あり
25 mg
$426.00
在庫あり
50 mg
$745.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

L-Isoleucine-13C6 is intended for use as an internal standard for the quantification of L-isoleucine by GC- or LC-MS. L-Isoleucine is an essential and branched-chain amino acid.1 It is an isomer of L-leucine and a diastereomer of L-alloisoleucine that functions as a nitrogen donor and has roles in glucose consumption, fatty acid metabolism, and immune function.1,2 Urinary levels of L-isoleucine are increased in patients with deficiencies in β-ketothiolase, short/branched-chain specific acyl-CoA dehydrogenase (SBCAD), or 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD), inborn errors of metabolism characterized by episodic ketoacidosis and neurological impairments.3

1.Nie, C., He, T., Zhang, W., et al.Branched chain amino acids: Beyond nutrition metabolismInt. J. Mol. Sci.19(4)954(2018) 2.Zhang, S., Zeng, X., Ren, M., et al.Novel metabolic and physiological functions of branched chain amino acids: A reviewJ. Anim. Sci. Biotechnol.810(2017) 3.Korman, S.H.Inborn errors of isoleucine degradation: A reviewMol. Genet. Metab.89(4)289-299(2006)

レビュー

Review for L-Isoleucine-13C6

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for L-Isoleucine-13C6

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.